Erica Lessem
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology 14
- HIV/AIDS drug development and treatment 3
-
- Pneumocystis jirovecii pneumonia detection and treatment 6
- Pneumonia and Respiratory Infections 3
-
- Pharmaceutical studies and practices 3
-
- Pharmaceutical Economics and Policy 4
-
- Biosimilars and Bioanalytical Methods 2
-
- Hepatitis C virus research 2
Erica Lessem
15 papers receiving 211 citations
Peers
Comparison fields: 5 of 57
- Infectious Diseases 180
- Epidemiology 132
- Applied Microbiology and Biotechnology 5
- Surgery 53
- Pediatrics, Perinatology and Child Health 21
Countries citing papers authored by Erica Lessem
This map shows the geographic impact of Erica Lessem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica Lessem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica Lessem more than expected).
Fields of papers citing papers by Erica Lessem
This network shows the impact of papers produced by Erica Lessem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica Lessem. The network helps show where Erica Lessem may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erica Lessem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 6 | |
| 2 | 2020 | 15 | |
| 3 | 2019 | 7 | |
| 4 | 2018 | 23 | |
| 5 | 2017 | 50 | |
| 6 | 2017 | 1 | |
| 7 | 2016 | 32 | |
| 8 | Falling Short of the Rights to Health and Scientific Progress: Inadequate TB Drug Research and Access. | 2016 | 8 |
| 9 | 2015 | 27 | |
| 10 | HIV, HEPATITIS C VIRUS (HCV), AND TUBERCULOSIS (TB) DRUGS, DIAGNOSTICS, VACCINES, PREVENTIVE TECHNOLOGIES, RESEARCH TOWARD A CURE, AND IMMUNE-BASED AND GENE THERAPIES IN DEVELOPMENT | 2015 | 1 |
| 11 | 2014 | 5 | |
| 12 | 2014 | 9 | |
| 13 | 2014 PIPELINE REPORT HIV, HEPATITIS C VIRUS (HCV), AND TUBERCULOSIS (TB) DRUGS, DIAGNOSTICS, VACCINES, PREVENTIVE TECHNOLOGIES, RESEARCH TOWARD A CURE, AND IMMUNE-BASED AND GENE THERAPIES IN DEVELOPMENT | 2014 | 1 |
| 14 | 2013 | 10 | |
| 15 | 2013 | 32 |
About Erica Lessem
Erica Lessem is a scholar working on Infectious Diseases, Epidemiology and Hepatology, having authored 15 papers that have together received 227 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (14 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Pharmaceutical Economics and Policy (4 papers), Pneumonia and Respiratory Infections (3 papers), HIV/AIDS drug development and treatment (3 papers), Pharmaceutical studies and practices (3 papers), Biosimilars and Bioanalytical Methods (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Infectious Diseases (180 citations), Epidemiology (132 citations) and Applied Microbiology and Biotechnology (5 citations). Erica Lessem has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Jennifer Furin, Grania Brigden, Mike Frick, Dalene von Delft, Vivian Cox, Phumeza Tisile, Jonathan Stillo, Helen Cox, Lindsay McKenna and Michael Rich. Their work appears in journals such as PLoS ONE, The Lancet Infectious Diseases and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.